Kenvue Becomes a Fully Independent Company Following Final Separation from Johnson & Johnson
23 Agosto 2023 - 7:25AM
Business Wire
Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its
separation from Johnson & Johnson, marking its first day as a
fully independent company.
“This is a historic moment for Kenvue and with a singular focus
on delivering innovative care solutions to customers and consumers
around the world, we’re excited to write the next chapter of
consumer health,” said Thibaut Mongon, Kenvue’s Chief Executive
Officer and Director. “Thank you to our passionate teams who have
prepared us for this significant milestone and welcome to our new
shareholders. As the home to some of the world's most beloved
brands, we step into the future as a fully independent company from
a position of strength and look forward to all that we will
continue to achieve as a global leader in consumer health.”
As separately announced today, Johnson & Johnson accepted an
aggregate of 190,955,436 shares of Johnson & Johnson common
stock in exchange for 1,533,830,450 shares of Kenvue common stock.
As a result, Johnson & Johnson now owns 9.5% of the outstanding
shares of Kenvue common stock. The exchange offer was 4.2x
subscribed.
Full details of the results are available in a separate press
release issued this morning by Johnson & Johnson.
Kenvue expects to also become the newest member of the S&P
500®. S&P Dow Jones Indices announced its intent to add Kenvue
to the S&P 500 index effective prior to the opening of trading
on August 25, 2023.
About Kenvue Kenvue is the
world’s largest pure-play consumer health company by revenue. Built
on more than a century of heritage, our iconic brands, including
Aveeno®, BAND-AID® Brand Adhesive Bandages, Johnson’s®, Listerine®,
Neutrogena®, and Tylenol®, are science-backed and recommended by
healthcare professionals around the world. At Kenvue, we believe in
the extraordinary power of everyday care and our teams work every
day to put that power in consumers’ hands and earn a place in their
hearts and homes.
Cautions Concerning Forward-Looking
Statements This press release contains “forward-looking
statements” as defined in the Private Securities Litigation Reform
Act of 1995 regarding future operating and financial performance.
Forward-looking statements may be identified by the use of words
such as “plans,” “expects,” “will,” “anticipates,” “estimates” and
other words of similar meaning. The reader is cautioned not to rely
on these forward-looking statements. These statements are based on
current expectations of future events. If underlying assumptions
prove inaccurate or known or unknown risks or uncertainties
materialize, actual results could vary materially from the
expectations and projections of Kenvue and its affiliates.
A list and descriptions of risks, uncertainties and other
factors can be found in Kenvue’s filings with the Securities and
Exchange Commission, including its registration statement on Form
S-1 and subsequent Quarterly Reports on Form 10-Q and other
filings, available at www.kenvue.com or on request from Kenvue.
Kenvue and its affiliates undertake no obligation to update any
forward-looking statements, whether as a result of new information,
future events or developments or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230822561972/en/
Investor Relations: Tina Romani Kenvue_IR@kenvue.com
Media Relations: Melissa Witt media@kenvue.com
Kenvue (NYSE:KVUE)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Kenvue (NYSE:KVUE)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024